THE USE OF DIURETICS IN ARTERIAL HYPERTENSION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Torasemide - loop diuretic, characterized by high bioavailability and favorable pharmacodynamic properties. The data on the clinical efficacy of torasemide in the treatment of patients with arterial hypertension and chronic heart failure, including in comparison with other loop diuretics, are presented. Due to unique pharmacological profile, pleiotropic properties, and neutral metabolic effect, torasemide has the advantage of other loop diuretics with regard to efficacy, safety, and treatment compliance in patients with arterial hypertension and chronic heart failure.

Full Text

Restricted Access

About the authors

G. I Nechayeva

FSBEI HE Omsk State Medical University of RMH

Email: profnechaeva@yandex.ru
MD, Prof., Head of the Department of Internal Diseases and Family Medicine FPE Omsk

T. V Tkachenko

FSBEI HE Omsk State Medical University of RMH

Omsk

E. V Semenova

FSBEI HE Omsk State Medical University of RMH

Omsk

References

  1. Кириченко А.А. Петлевые диуретики в практике терапевта. Рациональная фармакотерапия в кардиологии. Consilium medicinum. 2011; 13(1):58-63.
  2. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013;31(7): 1281-357.
  3. Карпов Ю.А. Торасемид: рекомендации для клинического применения при хронической сердечной недостаточности и артериальной гипертензии. РМЖ 2014;22(23.):1676-80.
  4. Савенков М.П., Кириченко А.В., Иванов С.Н., Соломонова Л.А., Иванова С.В. Антигипертензивный эффект петлевого диуретика торасемида. Consilium medicinum. 2011;13(5):11-4.
  5. Brater D.C. Torasemide. In: Cardiovascular drug therapy. Ed. F Messerli. 2 th ed. Philadelphia. 1996. Р 402-12.
  6. Claxton A.J., Cramer J., Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 2001; 23:1296-310.
  7. Achhammer I., Metz P. Low dose loop diuretics in essential hypertension. Experience with torasemide. Drugs. 1991;41(3):80-91.
  8. Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc. Drugs Ther. 1993;7(1):63-8.
  9. Friedel H., Buckley M. Torasemide. A review of its pharmacological properties and therapeutic potential. Drugs. 1991;41(1):81-103.
  10. Bolke T., Achhammer I. Torasemide: review of its pharmacology and therapeutic use. Drugs of Today. 1994;30(8):1-28.
  11. Ткачева О.Н., Шарашкина Н.В., Новикова И.М., Чухарева Н.А. Сравнительное исследование эффектов торасемида и гидрохлотиазида в комбинированном лечении гипертонической болезни у женщин в постменопаузе. Сердце. 2011;10(3, 59):1-5.
  12. Roca-Cusachs A., Aracil-Vilar J., Calvo-Gomez C., Vaquer-Pérez J.V., Laporta-Crespo F., Rojas-Serrano M.J., Guglietta A., Gropper S.; Torasemide-PR in Hypertension Clinical Trial Investigators Group. Clinical effects of torasemide prolonged release in mild-to-moderate hypertension: a randomized noninferiority trial versus torasemide immediate release. Cardiovasc. Ther. 2008;26(2):91-100.
  13. Spannbrucker N., Achhammer I., Metz P., Glocke M. Comparative study on the hypertensive efficacy of torasemide and indapamide in patients with essential hypertension. Drug Res. 1988;38 (1):190-93.
  14. Reyes A.J., Chiesa P.D., Santucci M.R., et al. Hydrochlorothiazide versus a nondiuretic dose of torasemide as once daily antihyper-tensive monopharmacotherapy in elderly patients; randomized and double-blind study In: Progress in Pharmacology and Clinical Pharmacology. Gustav-Fischer-Verlag: Stuttgart. 1990;8:183-209.
  15. Boelke T., Piesche L. Influence of 2,5-5 mg torasemide o.d. versus 25-50 mg HCTZ/50-100 triamterene o.d. on serum parameters in elderly patients with mild to moderate hypertension. In: Diuretics IV: Chemistry, Pharmacology and clinical Applications. Excerpta Medica. Amsterdam. 1993. Р 279-82.
  16. Achhammer I., Eberhard R. Comparison of serum potassium levels during long-term treatment of hypertension patients with 2,5 mg torasemide o.d. or 50 mg triamterene/25 mg hydrochlorothiazide o.d. In: Progress in Pharmacology and Clinical Pharmacology Gustav-Fischer-Verlag: Stuttgart. 1990;8:211-20.
  17. Boelke T., Achhammer I., Meyer-Sabellek W.A. Blutdrucksenkung und metabolische Veranderungen bei essentiellen Hypertonikem nach Langzeitgabe unterschiedlicher Diuretika. Hochdruck. 1990; 9:40-1.
  18. Porcellati C., Verdecchia P., Schillaci G., et al. La torasemide, nuovo diuretico del'ansa, nell trattamento dell'ipertensione ar-teriosa: Studio con trolla to in doppla cecita. Bas. Razion Terapia. 1990;20:407-10.
  19. Метелица В.И. Справочник по клинической фармакологии сердечно-сосудистых лекарственных средств. 3-е изд. М., 2005. С. 15-27.
  20. Risler T., Kramer B., Muller G. The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide. Drugs. 1991;41(3):69-79.
  21. Гендлин Г.Е., Рязанцева Е.Е. Роль диуретиков в лечении хронической сердечной недостаточности. Сердечная недостаточность. 2012;10:23-8.
  22. Фомин В.В. Свойства антагониста альдостерона у петлевого диуретика: случайность или необходимость? Справочник поликлинического врача. 2010;4:25-8.
  23. Моисеев С.В. Клиническая эффективность и безопасность применения петлевого диуретика торасемида. Кардиология. 2006;4:71-4.
  24. Stauch M., Stiehl M. Controlled double blind clinical trial on the efficacy and tolerance of torasemide in patients with congestive heart failure. A multi-center study. In: Progress in Pharmacology and Clinical Pharmacology Gustav-Fischer-Verlag. Stuttgart. 1990;8:121-26.
  25. Noe L.L., Vreeland M.G., Pezzella S.M., Trotter J.P. A pharmaeco-nomical assessment of torasemide and furosemide in the treatment of patients with congestive heart failure. Clin. Ther. 1999; 21:854-60.
  26. Cosin J., Diez J. TORIC investigators. Torasemide in chronic heart failure: results of the TORIC study. Eur. J. Heart Fail. 2002;4:507-13.
  27. Kasama S., Toyama T., Hatori T., Sumino H., Kumakura H., Takayama Y., Ichikawa S., Suzuki T., Kurabayashi M. Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure. Heart. 2006;92(10):1434-40.
  28. Lopez B., Querejeta R., González A., Sánchez E., Larman M., Diez J. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J. Am. Coll. Cardiol. 2007;50:859-67.
  29. TORAFIC Investigators Group. Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study. Clin. Ther. 2011;33(9): 1204-13.
  30. Muniz P., Fortuno A., Zalba G., Fortuño MA, Díez J. Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth. Nephrol. Dial. Transplant. 2001;16:14-7.
  31. De Berrazueta J.R., Gonzalez J.P., deMier I., Poveda J.J., García-Unzueta M.T. Vasodilatory action of loop diuretics: A plethysmography study of endothelial function in forearm arteries and dorsal hand veins in hypertensive patients and controls. J. Cardiovasc. Pharmacol. 2007;49:90-5.
  32. Fortuno A., Muniz P., Ravassa S., Rodriguez J.A., Fortuño M.A., Zalba G., Díez J. Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats. Hypertension. 1999;34(1):138-43.
  33. Friedel H., Buckley M.M. Torasemide. A review of its pharmacology and therapeutic potential. Drugs. 1991;41(1):81-103.
  34. Brunner G., Estrada E., Plesche L. Efficacy and safety of to-rasemide (5 to 40 mg o. d.) in the treatment of oedema in patients with hydrppically decompensated liver failure. Diuretics IV: Chemistry, Pharmacology and clinical Applications. Amsterdam: Excerpta Medica. 1993;4:27-30.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies